Literature DB >> 12404325

The use of stimulants in the treatment of post traumatic stress disorder: case report.

Oscar E Daly1.   

Abstract

Post Traumatic Stress disorder (PTSD) is a condition where the individual suffers re-experiencing phenomena, avoidance behaviour or emotional numbing and hyperarousal following a major traumatic event. Psychological treatments, primarily behavioural, and psychopharmacological interventions have been shown to be of considerable benefit. This case report describes an individual suffering from PTSD who experienced almost complete remission of her symptoms following the prescription of a centrally acting stimulant for unrelated reasons. The actions of centrally acting stimulants and the current knowledge about the neurophysiology of PTSD may help to explain the patient's recovery. Further investigation of amphetamine-like substances and related compounds in PTSD is required. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Year:  2000        PMID: 12404325     DOI: 10.1002/1099-1077(200006)15:4<295::AID-HUP166>3.0.CO;2-O

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  3 in total

1.  Psychostimulants for the Treatment of Comorbid Post-traumatic Stress Disorder (PTSD) in a Patient With Attention-Deficit/Hyperactivity Disorder (ADHD): A Case Report and Literature Summary.

Authors:  Claudette Barreto; Ana Vila Irigoyen; Olga Lopez; Leonard Gralnik
Journal:  Cureus       Date:  2022-08-20

2.  Methylphenidate and desipramine combined treatment improves PTSD symptomatology in a rat model.

Authors:  S Aga-Mizrachi; A Cymerblit-Sabba; O Gurman; A Balan; G Shwam; R Deshe; L Miller; N Gorodetsky; N Heinrich; O Tzezana; S Zubedat; D Grinstein; A Avital
Journal:  Transl Psychiatry       Date:  2014-09-23       Impact factor: 6.222

Review 3.  Diminished positive affect and traumatic stress: A biobehavioral review and commentary on trauma affective neuroscience.

Authors:  Gregory A Fonzo
Journal:  Neurobiol Stress       Date:  2018-10-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.